BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9377104)

  • 1. Immunostimulatory activities of mono- or diglycosylated alpha-galactosylceramides.
    Uchimura A; Shimizu T; Nakajima M; Ueno H; Motoki K; Fukushima H; Natori T; Koezuka Y
    Bioorg Med Chem; 1997 Jul; 5(7):1447-52. PubMed ID: 9377104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostimulatory activities of monoglycosylated alpha-D-pyranosylceramides.
    Uchimura A; Shimizu T; Morita M; Ueno H; Motoki K; Fukushima H; Natori T; Koezuka Y
    Bioorg Med Chem; 1997 Dec; 5(12):2245-9. PubMed ID: 9459022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulatory and antitumor activities of monoglycosylceramides having various sugar moieties.
    Motoki K; Morita M; Kobayashi E; Uchida T; Akimoto K; Fukushima H; Koezuka Y
    Biol Pharm Bull; 1995 Nov; 18(11):1487-91. PubMed ID: 8593464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 3alpha- and 3beta-galactosylated alpha-galactosylceramides on the immune system.
    Sakai T; Morita M; Matsunaga N; Akimoto K; Yokoyama T; Iijima H; Koezuka Y
    Bioorg Med Chem Lett; 1999 Mar; 9(5):697-702. PubMed ID: 10201831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha- and beta-galactosylated C2-ceramides on the immune system.
    Sakai T; Ueno H; Natori T; Uchimura A; Motoki K; Koezuka Y
    J Med Chem; 1998 Feb; 41(4):650-2. PubMed ID: 9484513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship and conformational analysis of monoglycosylceramides on the syngeneic mixed leukocyte reaction.
    Iijima H; Kimura K; Sakai T; Uchimura A; Shimizu T; Ueno H; Natori T; Koezuka Y
    Bioorg Med Chem; 1998 Oct; 6(10):1905-10. PubMed ID: 9839020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules.
    Sakai T; Naidenko OV; Iijima H; Kronenberg M; Koezuka Y
    J Med Chem; 1999 May; 42(10):1836-41. PubMed ID: 10346936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing effects of (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino) -1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells.
    Yamaguchi Y; Motoki K; Ueno H; Maeda K; Kobayashi E; Inoue H; Fukushima H; Koezuka Y
    Oncol Res; 1996; 8(10-11):399-407. PubMed ID: 9114432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.
    Ko SY; Ko HJ; Chang WS; Park SH; Kweon MN; Kang CY
    J Immunol; 2005 Sep; 175(5):3309-17. PubMed ID: 16116223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.
    Lacône V; Hunault J; Pipelier M; Blot V; Lecourt T; Rocher J; Turcot-Dubois AL; Marionneau S; Douillard JY; Clément M; Le Pendu J; Bonneville M; Micouin L; Dubreuil D
    J Med Chem; 2009 Aug; 52(15):4960-3. PubMed ID: 19580320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRN7000, a novel immunomodulator, and its antitumor activities.
    Kobayashi E; Motoki K; Uchida T; Fukushima H; Koezuka Y
    Oncol Res; 1995; 7(10-11):529-34. PubMed ID: 8866665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
    Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
    Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.
    Kitamura H; Iwakabe K; Yahata T; Nishimura S; Ohta A; Ohmi Y; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nishimura T
    J Exp Med; 1999 Apr; 189(7):1121-8. PubMed ID: 10190903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Th1-immunostimulatory activity of α-galactosylceramide analogues bearing a halogen-containing or selenium-containing acyl chain.
    Hossain MI; Hanashima S; Nomura T; Lethu S; Tsuchikawa H; Murata M; Kusaka H; Kita S; Maenaka K
    Bioorg Med Chem; 2016 Aug; 24(16):3687-95. PubMed ID: 27325450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha-galactosylceramides on bone marrow cells in vitro and hematopoiesis in vivo.
    Motoki K; Morita M; Kobayashi E; Uchida T; Fukushima H; Koezuka Y
    Biol Pharm Bull; 1996 Jul; 19(7):952-5. PubMed ID: 8839968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated liver dendritic cells generate strong acquired immunity in alpha-galactosylceramide treatment.
    Sasakawa A; Tatsumi T; Takehara T; Yamaguchi S; Yamamoto M; Ohkawa K; Miyagi T; Hayashi N
    J Hepatol; 2009 Jun; 50(6):1155-62. PubMed ID: 19376606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95.
    Gaspar-Elsas MI; Queto T; Masid-de-Brito D; Vieira BM; de Luca B; Cunha FQ; Xavier-Elsas P
    Br J Pharmacol; 2015 Jul; 172(13):3313-25. PubMed ID: 25752588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids.
    Parekh VV; Singh AK; Wilson MT; Olivares-Villagómez D; Bezbradica JS; Inazawa H; Ehara H; Sakai T; Serizawa I; Wu L; Wang CR; Joyce S; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3693-706. PubMed ID: 15356115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory potential of smokeless tobacco extract in in vitro cultures of murine lymphoid tissues.
    Goud SN; Zhang L; Kaplan AM
    Immunopharmacology; 1993; 25(2):95-105. PubMed ID: 8500987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NK-T cell activator (α-GalCer) accelerates immune and hematological reconstitution after murine allo-bone marrow transplantation].
    Liu JH; Zhou F; Dou LP; Liu YQ; Wang JG; Bai Y; Guo BY; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1542-7. PubMed ID: 21176367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.